Katalin Karikó and Drew Weissman Receive the Nobel Prize in Physiology or Medicine

Highlights:

Karikó and Weissman's base modifications revolutionized mRNA, enabling rapid vaccine development
mRNA vaccines heralded unprecedented speed and efficacy in the fight against COVID-19
Their work not only saved lives but changed the landscape of vaccine technology

The Nobel Assembly at Karolinska Institutet made a historic announcement, jointly awarding the 2023 Nobel Prize in Physiology or Medicine to Katalin Karikó and Drew Weissman. Their discoveries in nucleoside base modifications have revolutionized vaccine development, leading to the creation of highly effective mRNA vaccines against COVID-19.

From Breakthrough to Lifesaver: The Nobel-Winning mRNA Revolution

mRNA Vaccines: A Promising Paradigm

The advent of in vitro transcription in the 1980s heralded a new era in mRNA production. Yet, the inherent instability and inflammatory reactions associated with in vitro transcribed mRNA posed significant challenges.

Karikó and Weissman's Collaborative Endeavor

The collaboration between Katalin Karikó and Drew Weissman focused on dendritic cells, vital players in immune surveillance and vaccine-induced immune responses. Their pivotal observation that in vitro transcribed mRNA triggered an inflammatory response in dendritic cells led to an investigation of nucleoside base modifications.

Nobel Prize 2021 in Medicine Shared by Two US Scientists
US scientists won the 2021 Nobel Prize in Physiology or Medicine for discovering the mechanism of touch and temperature.

‘Karikó and Weissman's discovery led to mRNA vaccines with up to 95% efficacy. #nobelprize #vaccinerevolution #medindia’

Discovery of Nobel Prize Winning Vaccine

Karikó and Weissman’s revelation that chemically modified bases in RNA from mammalian cells averted inflammatory reactions marked a seismic shift in understanding cellular responses to different forms of mRNA.

The Significance of Base Modifications

Subsequent studies by the duo demonstrated that base modifications not only curtailed inflammatory responses but also significantly boosted protein production compared to unmodified mRNA. This research eliminated key obstacles in the clinical application of mRNA.

Realization of mRNA Vaccines' Potential:

Following their groundbreaking discoveries, interest in mRNA technology surged. By 2010, companies were already engaged in developing mRNA-based vaccines against various viruses. When the COVID-19 pandemic emerged, base-modified mRNA vaccines were created at an unprecedented pace. These vaccines exhibited remarkably high efficacy rates and received approval in December 2020.

Nobel Prize for the Discovery of the Evolution of the Human Race
Who is the Nobel Prize award winner in Medicine 2022? Svante Pääbo from Sweden has been awarded for studying our extinct ancestors' DNA.

Future Horizons of mRNA Vaccines

The extraordinary adaptability and swiftness with which mRNA vaccines can be developed pave the way for their utilization against other infectious diseases. Furthermore, this technology holds promise for delivering therapeutic proteins and treating specific types of cancer.

Vaccines as an Immunity Delivery Sytem

Vaccination has been a cornerstone in the fight against infectious diseases. Traditional vaccines, based on weakened or inactivated viruses, have been instrumental in controlling diseases like polio and measles.

Advances in molecular biology enabled the development of vaccines based on individual viral components, such as those against hepatitis B and human papillomavirus. Additionally, vector-based vaccines, like those targeting the Ebola virus, were introduced. However, large-scale cell culture requirements limited the speed of vaccine production during outbreaks and pandemics.

Duke Professor Wins New Nobel Award in Artificial Intelligence
Cynthia Rudin’s inspiring and insightful research with independent thinking has led her in directions very different from the mainstream to highlight the issues and problems of the practical, societal importance of artificial intelligence.

The development of mRNA vaccines marked a revolutionary stride in immunization strategies. Nucleic acids, particularly modified nucleosides, played a pivotal role.

As clinical trials, overseen by regulatory bodies like the Food and Drug Administration in the United States, assessed safety and efficacy, the public health response became a global effort. Vaccine manufacturers utilized advanced platforms, encapsulating the mRNA within lipid nanoparticles.

Here's Why Covid Vaccines Did Not Win Science Nobel
Development of mRNA vaccines is a wonderful success story that has had enormous positive consequences for humankind.

This delivery system ensured optimal interaction with the immune system while minimizing side effects. The European Medicines Agency and the World Health Organization collaborated closely, providing rigorous oversight and global recommendations. The successful production of vaccines against diseases like the Zika virus underscored the immense potential of this innovative approach, heralding a new era in vaccination science.

The joint awarding of the Nobel Prize in Physiology or Medicine for 2023 to Katalin Karikó and Drew Weissman signifies their momentous contributions to the development of mRNA vaccines against COVID-19. Their discoveries have not only saved countless lives but have also transformed our approach to vaccine development and unlocked new possibilities for therapeutic interventions in the future ().

"In the crucible of a global crisis, the brilliance of Karikó and Weissman illuminated a path towards hope. Their work has not only protected us today but has forged a legacy that will shape the future of medicine for generations to come."

Reference:

Press release: The Nobel Prize in Physiology or Medicine 2023 - (https://www.nobelprize.org/prizes/medicine/2023/press-release/)

Source-Medindia